In addition, we also assessed the capacity of the TrkB agonist 7,8-DHF in improving the core symptoms of ADHD after activating TrkB and the BDNF/P75 signal pathway. The gene discussed is NTRK2; the disease is attention deficit-hyperactivity disorder.